EnTellect Medical Holdings is a portfolio Company that focuses on deploying asset-centric resources to realize commercially viable medical devices. The Company is lead by clinical and industry experts with more than 50 years of combined experience. EMH focuses on funding initial clinical proof of concept and intellectual property that either justifies a new spin-off entity or a tuck-in technology for an existing portfolio Company. Entellect has a wide range of successes from NIH SBIR funded initiatives to purchase agreements with industry leading OEMs. The Company is currently focused on market shifting devices for endoscopy, specifically gastroenterology and endourology specialties.